Physician profile
Ellen Meredith Maher
NPI 1447637038
$432.59
in general payments reported to CMS, 2019-2025
14 companies · $34.78 in 2025
The $34.78 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $97.59 · 2023: $43.32 · 2024: $24.82 · 2025: $34.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $85.39 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $40.16 | 2019 | |
| Amgen INC. | $39.86 | 2019-2024 | Tezspire |
| Organon LLC | $34.78 | 2025 | Nexplanon |
| Janssen Pharmaceuticals, INC | $34.64 | 2019 | |
| Sanofi-Aventis U.S. LLC | $30.80 | 2019 | |
| Pfizer INC. | $27.82 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $24.62 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $24.15 | 2019 | |
| Mylan Specialty L.P. | $23.36 | 2023 | Yupelri |
| Xeris Pharmaceuticals, INC. | $19.96 | 2023 | Gvoke Hypopen |
| Allergan, INC. | $19.87 | 2019 | |
| Merck Sharp & Dohme LLC | $14.37 | 2020 | |
| Amarin Pharma, INC. | $12.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Maher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.